ES2175100T3 - Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen. - Google Patents
Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2175100T3 ES2175100T3 ES96919967T ES96919967T ES2175100T3 ES 2175100 T3 ES2175100 T3 ES 2175100T3 ES 96919967 T ES96919967 T ES 96919967T ES 96919967 T ES96919967 T ES 96919967T ES 2175100 T3 ES2175100 T3 ES 2175100T3
- Authority
- ES
- Spain
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- compounds
- piridazinonas
- adrenoceptores
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical compound C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 108060003345 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000017910 Adrenergic receptor Human genes 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 239000007858 starting material Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
ESTA INVENCION ESTA RELACIONADA CON UNA R 2 [3 ([1,4]BENZODIOXAN 2 ILMETILAMINO) 1 PROPIL] 3(2H) PIRIDAZINONA CON LA FORMULA (1), Y CON UNA S 2 [3 ([1,4]BENZODIOXAN 2 ILMETILAMINO) 1 PROPIL] 3(2H) PIRIDAZINONA CON LA FORMULA (2), Y CON LAS SALES ACIDAS DE ADICION DERIVADAS, ASI COMO AQUELLAS COMPOSICIONES FARMACEUTICAS QUE CONTENGAN ESTOS COMPUESTOS. ADEMAS, LA INVENCION ESTA RELACIONADA CON UN PROCESO PARA PREPARAR LOS COMPUESTOS ANTERIORES. LOS NUEVOS COMPUESTOS DE PARTIDA CON LAS FORMULAS (4) Y (5) TAMBIEN FORMAN PARTE DEL OBJETO DE ESTA INVENCION. DE ACUERDO CON ESTA INVENCION, ESTOS COMPUESTOS POSEEN EFECTOS ANTAGONISTAS DE LOS RECEPTORES ADRENERGICOS AL 1 Y AL 2 Y ACTIVIDAD UROGENITAL. EN CONSECUENCIA, SON UTILES EN EL TRATAMIENTO DE LA HIPERPLASIA BENIGNA DE PROSTATA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9501560A HU224067B1 (hu) | 1995-05-29 | 1995-05-29 | 3(2H)-Piridazinon-származékok és e vegyületeket tartalmazó gyógyszerkészítmények |
| PCT/HU1996/000030 WO1996038441A1 (en) | 1995-05-29 | 1996-05-28 | 3(2h)-pyridazinone derivatives and pharmaceutical compositions containing these compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2175100T3 true ES2175100T3 (es) | 2002-11-16 |
Family
ID=10986884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96919967T Expired - Lifetime ES2175100T3 (es) | 1995-05-29 | 1996-05-28 | Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US6194411B1 (es) |
| EP (1) | EP0869957B1 (es) |
| JP (2) | JP3857313B2 (es) |
| KR (1) | KR100408364B1 (es) |
| AT (1) | ATE214389T1 (es) |
| AU (1) | AU710265B2 (es) |
| CA (1) | CA2222724C (es) |
| DE (1) | DE69619861T2 (es) |
| DK (1) | DK0869957T3 (es) |
| ES (1) | ES2175100T3 (es) |
| HU (1) | HU224067B1 (es) |
| PT (1) | PT869957E (es) |
| WO (1) | WO1996038441A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU227237B1 (en) * | 2001-09-27 | 2010-12-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them |
| AU2006214233A1 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU195645B (en) * | 1985-10-30 | 1988-06-28 | Gyogyszerkutato Intezet | Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same |
-
1995
- 1995-05-29 HU HU9501560A patent/HU224067B1/hu not_active IP Right Cessation
-
1996
- 1996-05-28 EP EP96919967A patent/EP0869957B1/en not_active Expired - Lifetime
- 1996-05-28 AU AU58427/96A patent/AU710265B2/en not_active Ceased
- 1996-05-28 WO PCT/HU1996/000030 patent/WO1996038441A1/en not_active Ceased
- 1996-05-28 CA CA002222724A patent/CA2222724C/en not_active Expired - Fee Related
- 1996-05-28 KR KR1019970708521A patent/KR100408364B1/ko not_active Expired - Fee Related
- 1996-05-28 DE DE69619861T patent/DE69619861T2/de not_active Expired - Fee Related
- 1996-05-28 DK DK96919967T patent/DK0869957T3/da active
- 1996-05-28 AT AT96919967T patent/ATE214389T1/de not_active IP Right Cessation
- 1996-05-28 PT PT96919967T patent/PT869957E/pt unknown
- 1996-05-28 ES ES96919967T patent/ES2175100T3/es not_active Expired - Lifetime
- 1996-05-28 US US08/973,584 patent/US6194411B1/en not_active Expired - Fee Related
- 1996-05-28 JP JP53631996A patent/JP3857313B2/ja not_active Expired - Fee Related
-
2000
- 2000-08-28 US US09/649,077 patent/US6248907B1/en not_active Expired - Fee Related
-
2006
- 2006-06-01 JP JP2006153349A patent/JP2006316064A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP3857313B2 (ja) | 2006-12-13 |
| DK0869957T3 (da) | 2002-07-01 |
| JP2006316064A (ja) | 2006-11-24 |
| KR19990022042A (ko) | 1999-03-25 |
| CA2222724A1 (en) | 1996-12-05 |
| KR100408364B1 (ko) | 2004-06-14 |
| PT869957E (pt) | 2002-09-30 |
| EP0869957A2 (en) | 1998-10-14 |
| WO1996038441A1 (en) | 1996-12-05 |
| HU224067B1 (hu) | 2005-05-30 |
| HUT75104A (en) | 1997-04-28 |
| US6248907B1 (en) | 2001-06-19 |
| AU710265B2 (en) | 1999-09-16 |
| DE69619861D1 (de) | 2002-04-18 |
| AU5842796A (en) | 1996-12-18 |
| HU9501560D0 (en) | 1995-07-28 |
| ATE214389T1 (de) | 2002-03-15 |
| EP0869957B1 (en) | 2002-03-13 |
| CA2222724C (en) | 2006-05-23 |
| US6194411B1 (en) | 2001-02-27 |
| DE69619861T2 (de) | 2002-09-26 |
| JPH11506094A (ja) | 1999-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE11898A1 (es) | Nuevos inhibidores de la farnesiltransferasa, su preparacion y los compuestos farmaceuticos que los contienen | |
| ES2174989T3 (es) | Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion. | |
| ES2059377T3 (es) | Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos. | |
| ES2133754T3 (es) | Procedimiento de lavado esterilizador. | |
| ES2119984T3 (es) | Nuevos compuestos propinil bi-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| IS2598B (is) | Þíenópýrimidíndíón og notkun þeirra í mótun sjálfnæmissjúkdóma | |
| ES2142034T3 (es) | Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ES2164920T3 (es) | Nuevos derivados heterociclicos y uso medicinal de los mismos. | |
| ES2131106T3 (es) | Compuestos de benzotiazepina hipolipidemicos. | |
| ES2111092T3 (es) | Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos. | |
| BR0307406A (pt) | Indóis substituìdos como agonistas alfa-1 | |
| ES2163407T3 (es) | Derivados piperidinilos tiaciclicos. | |
| AR007241A1 (es) | Analogos de 20-epi-16-eno de vitamina d3, composiciones farmaceuticas que los contienen, procedimiento para la preparacion de dichos compuestos yempleo de dichos compuestos para la preparacion de composiciones farmaceuticas | |
| SE8703169L (sv) | 1-(4-aminofenyl)-4-metyl-7,8-metylendioxi-3,4-dihydro-5h-2,3-bensodiazepin, syraadditionssalter derav samt forfarande for framstellning av densamma | |
| ES2120145T3 (es) | Compuestos bi-aromaticos acetilenados con grupo adamantilo, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ES2143734T3 (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ES2119326T3 (es) | Compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| ES2174973T3 (es) | Derivados de 3-aril-1,2,4-triazol con propiedades herbicidas. | |
| ES2175328T3 (es) | Piperidonas como antagonistas de la taquiquinina. | |
| ES2062455T3 (es) | Nuevos derivados de benzonaftiridina-1,8, su preparacion y las composiciones que les contienen. | |
| AR001813A1 (es) | Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen | |
| ES2037709T3 (es) | Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas. | |
| ES2175100T3 (es) | Piridazinonas antagonistas de alfa1-adrenoceptores, su procedimiento de preparacion, y las composiciones farmaceuticas que los contienen. | |
| ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2086195T3 (es) | Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 869957 Country of ref document: ES |